Internal Medicine, Pulmonary Disease · Houston, TX
NPI
1669532891
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
6620 Main St
Houston, TX, 77030
Phone (713) 798-2500
Groups this clinician bills Medicare through
Medicare paid, 2024
$65K
708 services
Medicare patients, 2024
204
Average age 71
Drug cost, 2024
$19.3M
3,252 prescriptions
Company payments, 2025
$29K
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Zeenat Safdar was code 99233 (hospital e&m - subsequent), 267 times for 62 patients. In total Zeenat Safdar billed 708 services in 22 codes, and Medicare paid $65K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-01-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 267 | 62 | $92.32 | $25K |
| 99214 Office E&M - Established | Facility | 196 | 116 | $71.63 | $14K |
| 99215 Office E&M - Established | Facility | 42 | 39 | $110.47 | $4,640 |
| 99222 Hospital E&M - Initial | Facility | 38 | 32 | $98.96 | $3,760 |
| 99214 Office E&M - Established | Office | 37 | 29 | $98.18 | $3,633 |
| 99204 Office E&M - New | Facility | 24 | 24 | $95.62 | $2,295 |
By year: 2022 $65K for 812 services; 2023 $57K for 632 services; 2024 $65K for 708 services.
Medicare prescription drug claims, 2024
In 2024, the drug Zeenat Safdar prescribed most often to Medicare patients was Opsumit (Macitentan), with 445 prescriptions and refills. In total Zeenat Safdar wrote 3,252 Medicare prescriptions that cost $19.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Opsumit Macitentan | 445 | 445 | 48 | $5.6M |
| Ofev Nintedanib Esylate | 259 | 263 | 35 | $3.1M |
| Uptravi Selexipag | 183 | 187 | 19 | $3.9M |
| Furosemide Generic | 134 | 309 | 43 | $681 |
| Montelukast Sodium Generic | 133 | 319 | 40 | $1,713 |
| Azithromycin Generic | 132 | 178 | 71 | $818 |
| Orenitram Er Treprostinil Diolamine | 131 | 131 | Under 11 | $821K |
| Tadalafil Generic | 116 | 173 | 22 | $111K |
| Adempas Riociguat | 115 | 115 | 13 | $1.6M |
| Spironolactone Generic | 102 | 287 | 33 | $1,770 |
| Breo Ellipta Fluticasone/Vilanterol | 100 | 140 | 22 | $52K |
| Sildenafil Citrate Generic | 85 | 185 | 23 | $51K |
| Prednisone Generic | 79 | 191 | 37 | $450 |
| Digoxin Generic | 74 | 194 | 20 | $1,301 |
| Pirfenidone Generic | 72 | 80 | 13 | $252K |
Brand drugs: 1,705 claims; generic drugs: 1,547 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Zeenat Safdar $29K ($29K in general payments such as food, travel and fees) from 10 companies. The largest payer was Actelion Pharmaceuticals US, Inc. with $14K.
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. JNJ | 9 | $14K |
| United Therapeutics Corporation UTHR | 25 | $11K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $3,603 |
| Merck Sharp & Dohme LLC MRK | 4 | $234 |
| GlaxoSmithKline, LLC. GSK | 9 | $215 |
| Liquidia Technologies, Inc. | 2 | $162 |
| Insmed, Inc. INSM | 3 | $54.38 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $49.02 |
| Sandoz Inc. SDZ.SW | 1 | $21.86 |
| Inogen, Inc. INGN | 1 | $20.26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.